PACIFIC EDGE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.082 NZD | -2.38% |
|
-3.53% | -29.91% |
| Apr. 09 | Pacific Edge Reports Steady Growth in Bladder Cancer Test Volumes in Fiscal Q4 | MT |
| Mar. 14 | New Zealand Shares Flat on Thursday; Pacific Edge's Chair to Retire | MT |
Valuation
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 153.3 | 75.86 | 735.1 | 777.7 | 348.5 | 66.56 | - | - |
| Enterprise Value (EV) 1 | 140.4 | 61.08 | 714.8 | 672.3 | 271.9 | 18.91 | 43.04 | 47.93 |
| P/E ratio | -8.11 x | -3.44 x | -50.5 x | -36.9 x | -13 x | -2.33 x | -3.03 x | -4.18 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 40,152,329 x | 17,359,667 x | 72,871,735 x | 59,202,477 x | 14,914,910 x | - | - | - |
| EV / Revenue | 36,786,597 x | 13,976,600 x | 70,864,101 x | 51,177,812 x | 11,637,548 x | - | - | - |
| EV / EBITDA | -7.96 x | -3.24 x | -50.1 x | -33.4 x | -9.85 x | -0.64 x | -1.98 x | -2.91 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | 10.6 x | 5.23 x | 29.7 x | 7.18 x | 4.21 x | 1.24 x | 2.09 x | 2.71 x |
| Nbr of stocks (in thousands) | 510,871 | 689,652 | 727,779 | 810,087 | 810,365 | 811,721 | - | - |
| Reference price 2 | 0.3000 | 0.1100 | 1.010 | 0.9600 | 0.4300 | 0.0820 | 0.0820 | 0.0820 |
| Announcement Date | 5/28/19 | 5/29/20 | 5/27/21 | 5/25/22 | 5/24/23 | - | - | - |
1NZD in Million2NZD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 3.817 | 4.37 | 10.09 | 13.14 | 23.36 | - | - | - |
| EBITDA 1 | -17.64 | -18.83 | -14.28 | -20.11 | -27.59 | -29.68 | -21.77 | -16.46 |
| EBIT 1 | -18.03 | -19.13 | -14.58 | -20.53 | -29.73 | -31.38 | -23.72 | -18.32 |
| Operating Margin | -472.39% | -437.76% | -144.49% | -156.29% | -127.24% | - | - | - |
| Earnings before Tax (EBT) 1 | -17.71 | -18.89 | -14.22 | -19.79 | -26.96 | -29.16 | -19.5 | -14.09 |
| Net income 1 | -17.92 | -18.89 | -14.22 | -19.79 | -26.96 | -28.49 | -21.95 | -17.28 |
| Net margin | -469.43% | -432.17% | -141% | -150.64% | -115.42% | - | - | - |
| EPS 2 | -0.0370 | -0.0320 | -0.0200 | -0.0260 | -0.0330 | -0.0351 | -0.0271 | -0.0196 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 5/28/19 | 5/29/20 | 5/27/21 | 5/25/22 | 5/24/23 | - | - | - |
1NZD in Million2NZD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 |
|---|---|---|---|---|---|
| Net sales 1 | - | 7.011 | 12.49 | 10.87 | 14.69 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -10.94 | -11.67 | -18.06 | -17.14 |
| Operating Margin | - | -156.04% | -93.4% | -166.12% | -116.72% |
| Earnings before Tax (EBT) | - | - | - | -16.39 | - |
| Net income | -8.985 | - | - | -16.39 | - |
| Net margin | - | - | - | -150.83% | - |
| EPS | -0.0120 | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 11/25/21 | 5/25/22 | 11/23/22 | 5/24/23 | 11/22/23 |
1NZD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 12.8 | 14.8 | 20.3 | 105 | 76.6 | 47.6 | 23.5 | 18.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | -117% | - | -71.8% | -29.6% | -28.2% | -46.7% | -62.2% | -118% |
| ROA (Net income/ Total Assets) | -99.5% | -107% | -57.7% | -28% | -26.2% | -129% | -140% | -125% |
| Assets 1 | 18 | 17.72 | 24.65 | 70.59 | 103.1 | 22.07 | 15.64 | 13.83 |
| Book Value Per Share 2 | 0.0300 | 0.0200 | 0.0300 | 0.1300 | 0.1000 | 0.0700 | 0.0400 | 0.0300 |
| Cash Flow per Share 2 | -3.640 | -0.0300 | -0.0200 | -0.0200 | -0.0300 | -0.0300 | -0.0300 | -0.0200 |
| Capex 1 | 0.16 | 0.18 | 0.38 | 1.13 | 2.91 | 1.88 | 1.2 | 1.2 |
| Capex / Sales | 4.09% | 4.19% | 3.75% | 8.57% | 12.45% | - | - | - |
| Announcement Date | 5/28/19 | 5/29/20 | 5/27/21 | 5/25/22 | 5/24/23 | - | - | - |
1NZD in Million2NZD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.082
NZD
Average target price
0.135
NZD
Spread / Average Target
+64.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.91% | 39.47M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- PEB Stock
- Financials Pacific Edge Limited
